BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29548025)

  • 1. Top-down in the Long Term in Crohn's Disease.
    Boyapati RK; Ho GT; Satsangi J
    J Crohns Colitis; 2018 Apr; 12(5):513-514. PubMed ID: 29548025
    [No Abstract]   [Full Text] [Related]  

  • 2. [Medical management of pediatric Crohn's disease].
    Zeng Y; Gong S
    Zhonghua Er Ke Za Zhi; 2014 May; 52(5):345-8. PubMed ID: 24969931
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of Crohn's disease: step-up or top-down?].
    Herrlinger K; Stange EF
    Dtsch Med Wochenschr; 2010 Aug; 135(34-35):1694-8. PubMed ID: 20721847
    [No Abstract]   [Full Text] [Related]  

  • 4. Perioperative Management of Biologic and Immunosuppressive Medications in Patients With Crohn's Disease.
    Lightner AL
    Dis Colon Rectum; 2018 Apr; 61(4):428-431. PubMed ID: 29521822
    [No Abstract]   [Full Text] [Related]  

  • 5. Gastroduodenal Crohn's disease: medical management.
    Tremaine WJ
    Inflamm Bowel Dis; 2003 Mar; 9(2):127-8; discussion 131. PubMed ID: 12769447
    [No Abstract]   [Full Text] [Related]  

  • 6. Early combined immunosuppression in Crohn's disease.
    Badina L; Taddio A; Ventura A
    Lancet; 2008 Jun; 371(9629):1995; author reply 1996-7. PubMed ID: 18555906
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical therapy for Crohn's disease: top-down or step-up?
    Baert F; Caprilli R; Angelucci E
    Dig Dis; 2007; 25(3):260-6. PubMed ID: 17827952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug treatment of Crohn's disease].
    van Deventer SJ; Tytgat GN
    Ned Tijdschr Geneeskd; 1998 May; 142(21):1191-5. PubMed ID: 9627451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated cutaneous herpes simplex infection in a patient with Crohn's disease under azathioprine and steroids: First case report and literature review.
    Santos-Antunes J; Abreu C; Magro F; Coelho R; Vilas-Boas F; Andrade P; Lopes S; Macedo G
    J Crohns Colitis; 2014 Apr; 8(4):326-30. PubMed ID: 24257435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT.
    Singh S; Stitt LW; Zou G; Khanna R; Dulai PS; Sandborn WJ; Feagan BG; Jairath V
    Aliment Pharmacol Ther; 2019 May; 49(9):1188-1194. PubMed ID: 30891808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current focus on inflammatory intestinal diseases: Crohn's disease and ulcero-hemorrhagic rectocolitis].
    Fontaine F; Brassinne A; Delforge M; Demoulin JC; Drèze C; Gillard V; Bastens B
    Rev Med Liege; 1993 Nov; 48(11):593-618. PubMed ID: 7904768
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical therapy in Crohn's disease.
    Rogers AI; Coelho-Borges S
    Postgrad Med; 1992 Dec; 92(8):169-73, 177-8, 183 passim. PubMed ID: 1360652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive central nervous system aspergillosis in a patient with Crohn's disease after treatment with infliximab and corticosteroids.
    Bourne EL; Dimou J
    J Clin Neurosci; 2016 Aug; 30():163-164. PubMed ID: 27050914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk mitigation in Crohn's disease and ulcerative colitis: Session four summary.
    Leong RW
    J Gastroenterol Hepatol; 2021 Apr; 36 Suppl 1():27-28. PubMed ID: 33817847
    [No Abstract]   [Full Text] [Related]  

  • 15. Adenocarcinoma of the appendix associated with long-standing Crohn's disease.
    Almogy G; Fellig Y; Paz K; Durst A; Eid A
    Int J Colorectal Dis; 2001 Nov; 16(6):408-9. PubMed ID: 11760905
    [No Abstract]   [Full Text] [Related]  

  • 16. Systematic review with meta-analysis: prevalence, risk factors and costs of aminosalicylate use in Crohn's disease.
    Ma C; Dutton SJ; Cipriano LE; Singh S; Parker CE; Nguyen TM; Guizzetti L; Gregor JC; Chande N; Hindryckx P; Feagan BG; Jairath V
    Aliment Pharmacol Ther; 2018 Jul; 48(2):114-126. PubMed ID: 29851091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's sarcoma developing in a HIV-negative Crohn's disease patient shortly after azathioprine and corticosteroid treatment.
    Kilincalp S; Akıncı H; Hamamci M; Coşkun Y; Yüksel I
    J Crohns Colitis; 2014 Jun; 8(6):558-9. PubMed ID: 24291020
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of chronic inflammatory bowel disease based on evidence and according to stage: top down].
    Mudter J; Neurath MF
    Dtsch Med Wochenschr; 2013 Sep; 138(36):1779. PubMed ID: 24002879
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: pro.
    Hyams JS
    Inflamm Bowel Dis; 2005 Feb; 11(2):197-9. PubMed ID: 15677914
    [No Abstract]   [Full Text] [Related]  

  • 20. [Conservative therapy of ulcerative colitis and Crohn disease].
    Rasenack J; Kreisel W
    Fortschr Med; 1991 Apr; 109(11):245-7. PubMed ID: 1855750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.